Chin Lee
Technik-/Wissenschafts-/F&E-Leiter bei ALLAKOS INC.
Vermögen: 334 310 $ am 30.04.2024
Aktive Positionen von Chin Lee
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ALLAKOS INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Karriereverlauf von Chin Lee
Ehemalige bekannte Positionen von Chin Lee
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Abbott Biotech, Inc. | Corporate Officer/Principal | - | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
| THERAVANCE BIOPHARMA, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
| CONNECT BIOPHARMA HOLDINGS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2022 | - |
Ausbildung von Chin Lee
| The University of North Carolina at Chapel Hill | Doctorate Degree |
| Northwestern University | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 9 |
Operativ
| Chief Tech/Sci/R&D Officer | 4 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| CONNECT BIOPHARMA HOLDINGS LIMITED | Health Technology |
| THERAVANCE BIOPHARMA, INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| ALLAKOS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Abbott Biotech, Inc. |
